Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 9
2021 12
2022 14
2023 21
2024 14
2025 18
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for konstantinos venetis
Search for Kostantinos Venetis instead (1 results)
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.
Ivanova M, Porta FM, D'Ercole M, Pescia C, Sajjadi E, Cursano G, De Camilli E, Pala O, Mazzarol G, Venetis K, Guerini-Rocco E, Curigliano G, Viale G, Fusco N. Ivanova M, et al. Among authors: venetis k. Virchows Arch. 2024 Jan;484(1):3-14. doi: 10.1007/s00428-023-03656-w. Epub 2023 Sep 28. Virchows Arch. 2024. PMID: 37770765 Free PMC article. Review.
Cancer in a drop: Advances in liquid biopsy in 2024.
Borea R, Saldanha EF, Maheswaran S, Nicolo E, Singhal S, Pontolillo L, de Miguel Perez D, Venetis K, Dipasquale A, Ghazali N, Pisapia P, Franco AO, Gouda MA, Reduzzi C. Borea R, et al. Among authors: venetis k. Crit Rev Oncol Hematol. 2025 Sep;213:104776. doi: 10.1016/j.critrevonc.2025.104776. Epub 2025 May 28. Crit Rev Oncol Hematol. 2025. PMID: 40447209 Review.
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial.
Marvaso G, Corrao G, Zaffaroni M, Vincini MG, Lorubbio C, Gandini S, Fodor C, Netti S, Zerini D, Luzzago S, Mistretta FA, Venetis K, Cursano G, Burla T, Mazzocco K, Cattani F, Petralia G, Fusco N, Pravettoni G, Musi G, De Cobelli O, Tang C, Ost P, Palma DA, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Among authors: venetis k. Lancet Oncol. 2025 Mar;26(3):300-311. doi: 10.1016/S1470-2045(24)00730-7. Lancet Oncol. 2025. PMID: 40049196 Clinical Trial.
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy.
Venetis K, Cursano G, Scafetta R, Giachetti PPMB, Concardi A, De Camilli E, D'Ercole M, Mane E, Frascarelli C, Marra A, Gandini S, Pepe F, Scagnoli S, Rossi SM, Troiano R, Speziale E, De Angelis C, Troncone G, Malapelle U, Perrone G, Botticelli A, Viale G, Curigliano G, Guerini Rocco E, Criscitiello C, Fusco N. Venetis K, et al. Breast Cancer Res. 2025 May 14;27(1):79. doi: 10.1186/s13058-025-02020-x. Breast Cancer Res. 2025. PMID: 40369610 Free PMC article.
Liquid biopsy: Cell-free DNA based analysis in breast cancer.
Venetis K, Cursano G, Pescia C, D'Ercole M, Porta FM, Blanco MC, Frascarelli C, Ivanova M, Guerini Rocco E, Fusco N. Venetis K, et al. J Liq Biopsy. 2023 Jul 27;1:100002. doi: 10.1016/j.jlb.2023.100002. eCollection 2023 Sep. J Liq Biopsy. 2023. PMID: 40027284 Free PMC article. Review.
Trop-2 as an Actionable Biomarker in Breast Cancer.
Cursano G, Frigo E, Sajjadi E, Ivanova M, Venetis K, Guerini-Rocco E, Criscitiello C, Curigliano G, Fusco N. Cursano G, et al. Among authors: venetis k. Curr Genomics. 2023 Nov 22;24(3):129-131. doi: 10.2174/1389202924666230726112233. Curr Genomics. 2023. PMID: 38178982 Free PMC article. No abstract available.
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer.
Guerini-Rocco E, Venetis K, Cursano G, Mane E, Frascarelli C, Pepe F, Negrelli M, Olmeda E, Vacirca D, Ranghiero A, Trapani D, Criscitiello C, Curigliano G, Rolfo C, Malapelle U, Fusco N. Guerini-Rocco E, et al. Among authors: venetis k. Crit Rev Oncol Hematol. 2024 Sep;201:104427. doi: 10.1016/j.critrevonc.2024.104427. Epub 2024 Jun 23. Crit Rev Oncol Hematol. 2024. PMID: 38917944 Review.
85 results